Eric Venker, President & COO at Roivant Sciences Ltd. (ROIV), sold 100,000 shares at $11.45 ($1.1M) on 2025-06-20, disclosed to the SEC on 2025-06-24.
Scheduled sale ($1.1M) by President & COO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| ROIV | SELL | 2026-09-01 | $7.2M | — | Filing → |
| ROIV | SELL | 2026-07-29 | $7.0M | — | Filing → |
| IMVT | SELL | 2026-07-06 | $119K | — | Filing → |